학술논문

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial
Document Type
Article
Author
De Castro, N.Molina, J.-M.Delaugerre, C.Marcy, O.Chazallon, C.Anglaret, X.Messou, E.Eholié, S.N'takpe, J.-B.Bhatt, N.Khosa, C.Timana Massango, I.Laureillard, D.Chau, G.D.Domergue, A.Veloso, V.Escada, R.Wagner Cardoso, S.Grinsztejn, B.Irmine, A.Kakou, A.Ana cláudia, A.Jacqueline, A.Bonzou, A.Xavier, A.Amani, A.Khalide, A.Débora Faber, B.Rui, B.D.S.Aurélie, B.Nilesh, B.Antoine, B.Maryline, B.Kim Nhung, B.T.Luiz, C.Tung khanh, C.Corine, C.Lara, C.Mai Luong, C.T.Robson Pierre, D.S.Minh Há, D.T.Lehi Florence, D.Nathalie, D.C.Marie, D.S.Constance, D.Alpha, D.Thanh, D.P.Donald, D.Giang, D.C.Trang, D.H.T.Anaïs, D.Trang Quynh Nhu, D.B.V.H.Fulgence, E.Serge, E.Frederick, E.Arlette, E.Rodrigo, E.Etienne, E.Salimata, F.Ana cristina, F.Robert, G.Joachim, G.Tatiane, G.Maura lassance, G.Beatriz, G.Frederique, G.Thanh Trang Do, H.Brenda, H.Anh Phuong, H.Khanh thu, H.H.Marcelin, I.Jean-claude, K.Samuel, K.Sophie, K.Mc, K.Celso, K.Lambert, K.Romuald, K.Fatoumata, K.Suzanne, K.Martin, K.Tânia, K.Georgette, L.Didier, L.Jérôme, L.C.Khanh, L.G.Ngoc bich, L.T.Flávia, L.Van Duong, L.Anh Que, L.Huyen Thi Thu, M.Thu Huyen Nguyet, M.Emelva, M.Olivier, M.Luana, M.Lectícia, M.Hervé, M.Eugène, M.Jean-michel, M.Alice, M.Ronaldo ismerio, M.Jean-baptiste, N.Sandro, N.Cao van thi, N.Nuoi THI, N.Bang, N.D.Lân, N.H.Lan, N.N.Viet, N.N.Hong, N.T.Dilário, N.Hang THU, P.Anh THI QUYNH, P.Diane, P.Miresta, P.Cyprien, R.Delphine, R.Daniel, R.Claire, R.Valéria rita, R.Jorge, R.Lucimar, S.Soraia, S.D.M.Desiree, S.Yamissa, S.Bertine, S.Nádia, S.Anne-marie, T.Isabel cristina, T.Ezio, T.D.S.F.Cecile, T.Isabel, T.Thomas-d'aquin, T.Thiago, T.Thao PHAM PHUONG, T.Loc HUU, T.Quy Thi Kim, T.Tien Thi Thuy, T.Ton, T.Thi Hieu Nhi, T.Thi-Hai Ly, T.Valdilea, V.Arlindo, V.Xuan Thinh, V.Adolfo, V.Sandra, W.Alcina, Z.Astrid
Source
In: The Lancet Infectious Diseases. (The Lancet Infectious Diseases, June 2021, 21(6):813-822)
Subject
Language
English
ISSN
14744457
14733099